Table 3.
Comparison of prospective study patients with historical control group
| Prospective study patients | Historical control group n = 27 | P value | |
|---|---|---|---|
| Age (mean ±SD) |
44 ±14 years |
49 ±13 years |
P=0.14 |
| Male |
62% |
85% |
P=0.03 |
|
Race/ethnicity: | |||
| Caucasian |
69% |
41% |
P=0.21 |
| Indian subcontinent |
11% |
4% |
|
| Other |
20% |
22% |
|
| Missing |
0% |
33% |
|
|
Cause of ESRD: | |||
| Glomerular |
25% |
33% |
|
| Polycystic disease |
18% |
11% |
|
| Other known cause |
51% |
41% |
|
| Unknown |
6% |
15% |
P=0.41 |
|
BMI: | |||
| Mean ±SD |
28 ±5 |
29 ±6 |
P=0.57 |
| ≤30 |
70% |
56% |
P=0.23 |
| >30 |
30% |
33% |
|
| Missing |
0% |
11% |
|
| Preemptive transplantation |
27% |
37% |
P=0.34 |
| Living donor |
96% |
22% |
P<0.0001 |
|
Diabetes at 6 months: | |||
| Euglycemic |
88% |
67% |
P=0.07 |
| Impaired |
8% |
15% |
|
| NODAT |
4% |
18% |
|
| AR at 6 months | 2% | 15% | P=0.033 |
AR, acute rejection; BMI, body mass index; ESRD, end stage renal disease; NODAT, new onset diabetes after transplantation; SD, standard deviation.